Keyphrases
Multiple Myeloma
100%
During Pregnancy
81%
Myeloma Cells
71%
Chronic Lymphocytic Leukemia
66%
Chemotherapy
63%
Fluorescence in Situ Hybridization
62%
Pregnant Women
53%
First Trimester
49%
Lymphoma
47%
Non-Hodgkin Lymphoma
46%
Chronic Myeloid Leukemia
38%
Fetus
37%
Placenta
37%
Simvastatin
35%
Cancer in Pregnancy
35%
Non-pregnant Women
34%
Leukemia Patients
33%
Lymphoma Patients
32%
Malignancy
32%
Breast Cancer Cells
30%
Tetraspanin
30%
Doxorubicin
29%
Bone Marrow
29%
Eukaryotic Translation Initiation Factor 4E (eIF4E)
27%
Human Mesenchymal Stem Cells (hMSCs)
27%
Leukemia
26%
Translation Initiation
25%
Confidence Interval
23%
Apoptosis
23%
Enalapril
23%
Statins
23%
Heat Shock Protein 27 (HSP27)
22%
Polycythemia Vera
21%
Mesenchymal Stem Cells
21%
Microvesicles
21%
Hematological Malignancies
21%
B-CLL
21%
Essential Thrombocythemia
20%
Breast Cancer
20%
Risk Factors
19%
Acute Coronary Syndrome
19%
Fetal Outcome
18%
Acute Myeloblastic Leukemia
18%
Aneuploidy
18%
B-cell Lymphoma 2 (Bcl-2)
18%
Hazard Ratio
17%
Hodgkin Lymphoma
17%
Termination of Pregnancy
17%
Human Placenta
17%
Pregnancy-associated Cancer
16%
Medicine and Dentistry
Multiple Myeloma
81%
Malignant Neoplasm
78%
Breast Cancer
50%
Cancer
49%
First Trimester Pregnancy
45%
Myeloma Cell
43%
Cancer Cell
39%
Non-Hodgkin Lymphoma
37%
Diseases
37%
Placenta
33%
B-Cell Chronic Lymphocytic Leukemia
28%
Hodgkin's Lymphoma
25%
Doxorubicin
22%
Congenital Malformation
22%
Translation Initiation
21%
Tetraspanin
20%
Bone Marrow Mesenchymal Stem Cell
19%
Myeloma Cell Line
18%
In Vitro
18%
Mesenchymal Stem Cell
17%
Chronic Myelogenous Leukemia
17%
Ischemic Heart Disease
17%
Metastatic Carcinoma
17%
Pregnancy Termination
17%
Fluorescence in Situ Hybridization
17%
Leukemia
16%
Neoplasm
16%
Initiation Factor 4E
16%
Cardiovascular Disease
15%
Hematologic Malignancy
15%
Multiple Myeloma Cell Line
15%
Maturity Onset Diabetes of the Young
15%
Initiation Factor
14%
Biopsy Technique
13%
Patient with Non-Hodgkins Lymphoma
13%
Extracellular Matrix
13%
Melanoma
13%
Simvastatin
13%
Cell Migration
13%
Myeloma
13%
Cell Death
12%
Diabetes Mellitus
12%
Leukocyte
11%
Flow Cytometry
11%
MCF-7
11%
Cervical Cancer
11%
Acute Leukemia
11%
Antiphospholipid Syndrome
11%
Radiation Therapy
10%
Magnetic Resonance Imaging
10%